We currently do not have sufficient information about the CEO.
Key information
Daniel Kwabena Kissi
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
no data
CEO ownership
n/a
Management average tenure
no data
Board average tenure
3yrs
Recent management updates
Recent updates
CEO
Daniel Kwabena Kissi (57 yo)
no data
Tenure
Mr. Daniel Kwabena Apeagyei Kissi has been Managing Director of Ayrton Drugs Manufacturing Company Ltd. since December 01, 2012 and also it's Chief Executive Officer. He has been Chief Executive Officer an...
Board Members
Name
Position
Tenure
Compensation
Ownership
Theophilus Amarteifio
Executive Chairman
no data
no data
no data
Daniel Kwabena Kissi
CEO & Executive Director
no data
no data
no data
Henry Ocansey
CFO & Executive Director
3yrs
no data
no data
Kwasi Yirenkyi
Chief Corporate Affairs & Communications Officer and Non-Executive Director
3yrs
no data
no data
Alex Kwabena Bonney
Non-Executive Director
no data
no data
no data
Barima Afrane
Non-Executive Director
no data
no data
no data
Amarteokor Amarteifio
Non-Executive Director
no data
no data
no data
Benjamin Agyeman
Non-Executive Director
3yrs
no data
no data
Moritz Acquah
Non-Executive Director
1.9yrs
no data
no data
3.0yrs
Average Tenure
73yo
Average Age
Experienced Board: DASPHARMA's board of directors are considered experienced (3 years average tenure).